MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.
about
Mass spectrometry analysis for amyloidosis typing - is the future bright for its clinical implementation?Mass spectrometry imaging for clinical research - latest developments, applications, and current limitations.Advances in proteomic study of cardiac amyloidosis: progress and potential.MALDI Mass Spectrometry Imaging: A Novel Tool for the Identification and Classification of Amyloidosis.Systemic amyloidoses and proteomics: The state of the art.
P2860
MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
MALDI-mass spectrometry imagin ...... nstituent of amyloid deposits.
@ast
MALDI-mass spectrometry imagin ...... nstituent of amyloid deposits.
@en
type
label
MALDI-mass spectrometry imagin ...... nstituent of amyloid deposits.
@ast
MALDI-mass spectrometry imagin ...... nstituent of amyloid deposits.
@en
prefLabel
MALDI-mass spectrometry imagin ...... nstituent of amyloid deposits.
@ast
MALDI-mass spectrometry imagin ...... nstituent of amyloid deposits.
@en
P2860
P50
P356
P1476
MALDI-mass spectrometry imagin ...... nstituent of amyloid deposits.
@en
P2093
Martin Winter
Sandra Krüger
P2860
P304
P356
10.1369/0022155415595264
P577
2015-06-22T00:00:00Z